
1. clin infect dis. 2018 nov 13;67(11):1670-1676. doi: 10.1093/cid/ciy364.

large-scale artemisinin-piperaquine mass drug administration without
primaquine dramatically reduces malaria highly endemic region africa.

deng c(1), huang b(1), wang q(1)(2), wu w(2), zheng s(2), zhang h(2), li d(2),
feng d(2), li g(2), xue l(2), yang t(2), tuo f(2), mohadji f(3), su xz(4), xu
q(1), wu z(5), lin l(5), zhou j(6), yan h(2), bacar a(7), said abdallah k(7),
kéké ra(7), msa mliva a(3), mohamed m(3), wang x(8), huang s(9), oithik f(3), li 
xb(2), lu f(10)(11), fay mp(12), liu xh(13), wellems te(4), song j(1)(2).

author information: 
(1)institute tropical medicine, people's republic china.
(2)science technology park, guangzhou university chinese medicine,
guangdong, people's republic china.
(3)ministry health comoros, moroni, union comoros, bethesda, maryland.
(4)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, bethesda, maryland.
(5)first affiliated hospital, people's republic china.
(6)traditional chinese medicine college, guangzhou university chinese
medicine, guangdong, people's republic china.
(7)national malaria control programme, moroni, union comoros, people's
republic china.
(8)guangzhou medical university, people's republic china.
(9)school stomatology, jinan university, people's republic china.
(10)department parasitology, zhongshan school medicine, people's republic
of china.
(11)key laboratory tropical disease control ministry education, sun
yat-sen university, guangdong, people's republic china.
(12)biostatistics research branch, national institute allergy infectious
diseases, national institutes health, rockville, maryland.
(13)first affiliated hospital, guangzhou university chinese medicine,
guangdong, people's republic china.

background: mass drug administration (mda), without low-dose primaquine
(pmqld), considered malaria elimination programs. potential of
pmqld block malaria transmission mosquitoes must balanced against
liabilities use.
methods: artemisinin-piperaquine (ap), without pmqld, administered in
3 monthly rounds across anjouan island, union comoros. plasmodium falciparum
malaria rates, mortality, parasitemias, adverse events, pfk13 kelch-propeller
gene polymorphisms evaluated.
results: coverage 85 93% anjouan population achieved ap
plus pmqld (ap+pmqld) 2 districts (population 97164) ap alone 5
districts (224471). months april-september 2012 2013, 
average monthly malaria hospital rates per 100000 people fell 310.8 2.06 
in ap+pmqld population (ratio 2.06/310.8 = 0.66%; 95% ci: 0.02%, 3.62%; p =
.00007) 412.1 2.60 ap population (ratio 0.63%; 95% ci: 0.11%, 
1.93%; p < .00001). effectiveness ap+pmqld 0.9908 (95% ci: 0.9053,
0.9991), effectiveness ap alone 0.9913 (95% ci: 0.9657, 0.9978).
both regimens well tolerated, without severe adverse events. analysis 52 
malaria samples mda showed evidence selection pfk13
kelch-propeller mutations.
conclusions: steep reductions malaria cases achieved 3 monthly rounds 
of either ap+pmqld ap alone, suggesting potential highly successful mda
without pmqld epidemiological settings anjouan. major
challenge sustain expand public health benefits malaria
reductions mda.

doi: 10.1093/cid/ciy364 
pmcid: pmc6455902
pmid: 29846536  [indexed medline]

